Which pharmaceutical advertising innovation first allowed direct-to-consumer (DTC) prescription drug TV commercials to mention both the condition AND the drug name without listing all side effects verbally?

In the highly regulated world of pharmaceutical marketing, certain campaigns have revolutionized how medical products are advertised to both healthcare professionals and patients. This poll tests your knowledge about a groundbreaking shift in medical product advertising that changed the industry landscape. Do you know which marketing innovation truly transformed pharmaceutical promotion in the United States?

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

The FDA's 'brief summary' provision of 1997 that allowed side effects to appear in accompanying print references
The Medical Marketing Modernization Act of 2002 that removed restrictions on broadcast advertising for prescription medications
The Pharmaceutical Research Digital Guidelines of 1999 that created the first standardized warning templates
The Healthcare Communication Freedom Act of 1995 that deregulated all prescription drug marketing